๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safety and tolerability of high-dose quetiapine in treatment refactory schizophrenia: Preliminary results from an open-label trial

โœ Scribed by Nelson, M.W.; Reynolds, R.L.; Kelly, D.L.; Richards, C.M.; Conley, R.R.


Book ID
122638663
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
129 KB
Volume
60
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Safety, tolerability, and feasibility of
โœ Gihyun Yoon; Suck Won Kim; Paul Thuras; Joseph Westermeyer ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

Objective Prior trials testing standard-dose naltrexone (50 mg/day) have generated mixed results in the treatment of alcohol dependence. The purpose of this study was to evaluate the short-term safety, tolerability, and feasibility of high-dose naltrexone (150 mg/day) for treating alcohol-dependent